Literature DB >> 29909890

Obturators versus flaps after maxillary oncological ablation: A systematic review and best evidence synthesis.

Yubin Cao1, Changhao Yu2, Wei Liu3, Cheng Miao4, Bo Han5, Jianong Yang6, Longjiang Li7, Chunjie Li8.   

Abstract

Maxillary defects can be resolved by prosthetic obturation, autologous tissue reconstruction, or a combination of both. However, there is still controversy in the selection of the optimal approach. Therefore, the aim of this study was to systematically review evidences comparing the performance of obturators and flaps in patients after maxillary oncological ablation. Both electronic and manual searching approaches were conducted to identify eligible evidence. Two reviewers independently assessed the risk of bias. In addition, the same reviewers independently extracted the data. Meta-analyses were performed using Revman 5.3, and best evidence synthesis was performed. Sixteen studies were included and a total of 528 participants were analyzed. All studies were assessed at low quality. Results of this meta-analysis showed weak evidence in the difference between obturators and flaps on the outcome regarding word intelligibility (P = 0.004) and masticatory efficiency (P = 0.002). However, no differences were detected regarding speech intelligibility and nasalance. All studies were compiled into the best evidence synthesis. The sum of 31 evidences was considered. Twelve evidences were evaluated at a moderate level, such as speech, mastication, pain, salivation, taste sensations, and mouth opening. Except the outcomes of word intelligibility, masticatory efficiency, and mouth pain, other moderate evidences showed no difference between obturators and flaps. In conclusion, both obturators and flaps might be effective in patients' rehabilitation functions after maxillary ablation. However, some advantages were observed when using surgical reconstruction over prosthetic rehabilitation. Additional high-quality studies are needed to provide more solid evidence before applying these results into clinical practice.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Maxillectomy; Obturators; Prosthetic rehabilitation; Surgical flaps; Surgical reconstruction; Systematic review

Mesh:

Year:  2018        PMID: 29909890     DOI: 10.1016/j.oraloncology.2018.05.019

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

Review 1.  Palatomaxillary Reconstruction: Fibula or Scapula.

Authors:  Arvind K Badhey; Mohemmed N Khan
Journal:  Semin Plast Surg       Date:  2020-05-06       Impact factor: 2.314

2.  Mastication in maxillectomy patients: A comparison between reconstructed maxillae and implant supported obturators: A cross-sectional study.

Authors:  Doke J M Buurman; Caroline M Speksnijder; Reilly J de Groot; Peter Kessler; Jana M Rieger
Journal:  J Oral Rehabil       Date:  2020-07-13       Impact factor: 3.837

3.  Evaluation and comparison of oral function after resection of cancer of the upper gingiva in patients who underwent reconstruction surgery versus those treated with a prosthesis.

Authors:  Yu Ohashi; Kiyoto Shiga; Katsunori Katagiri; Daisuke Saito; Shin-Ichi Oikawa; Kodai Tsuchida; Aya Ikeda; Jun Miyaguchi; Takahiro Kusaka; Hiroyuki Yamada
Journal:  BMC Oral Health       Date:  2021-07-15       Impact factor: 2.757

4.  Strategic use of obturator prostheses for the rehabilitation of oral cancer patients during the COVID-19 pandemic.

Authors:  Thais Bianca Brandão; Cesar Augusto Migliorati; Aljomar José Vechiato-Filho; Wagner Gomes Silva; Ana Carolina Prado Ribeiro; Orlando Parise-Junior; Luiz Paulo Kowalski; Alan Roger Santos-Silva
Journal:  Support Care Cancer       Date:  2020-08-28       Impact factor: 3.603

5.  A New Strategy for Patient-Specific Implant-Borne Dental Rehabilitation in Patients With Extended Maxillary Defects.

Authors:  Philippe Korn; Nils-Claudius Gellrich; Philipp Jehn; Simon Spalthoff; Björn Rahlf
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.